The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study

被引:471
作者
Burslem, George M. [1 ]
Smith, Blake E. [1 ]
Lai, Ashton C. [1 ]
Jaime-Figueroa, Saul [1 ]
McQuaid, Daniel C. [1 ]
Bondeson, Daniel P. [1 ]
Toure, Momar [1 ]
Dong, Hanqing [2 ]
Qian, Yimin [2 ]
Wang, Jing [2 ]
Crew, Andrew P. [2 ]
Hines, John [1 ]
Crews, Craig M. [1 ,3 ,4 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St, New Haven, CT 06520 USA
[2] Arvinas LLC, 5 Sci Pk, New Haven, CT USA
[3] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[4] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA
关键词
GROWTH-FACTOR RECEPTOR; KINASE INHIBITOR; BREAST-CANCER; C-MET; TYROSINE KINASES; LUNG-CANCER; HSP90; UBIQUITINATION; RESISTANCE; TIVANTINIB;
D O I
10.1016/j.chembiol.2017.09.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteolysis targeting chimera (PROTAC) technology has emerged over the last two decades as a powerful tool for targeted degradation of endogenous proteins. Herein we describe the development of PROTACs for receptor tyrosine kinases, a protein family yet to be targeted for induced protein degradation. The use of VHL-recruiting PROTACs against this protein family reveals several advantages of degradation over inhibition alone: direct comparisons of fully functional, target-degrading PROTACs with target-inhibiting variants that contain an inactivated E3 ligase-recruiting ligand show that degradation leads to more potent inhibition of cell proliferation and a more durable and sustained downstream signaling response, and thus addresses the kinome rewiring challenge seen with many receptor tyrosine kinase inhibitors. Combined, these findings demonstrate the ability to target receptor tyrosine kinases for degradation using the PROTAC technology and outline the advantages of this degradation-based approach.
引用
收藏
页码:67 / +
页数:14
相关论文
共 64 条
[31]   Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras [J].
Lebraud, Honorine ;
Wright, David J. ;
Johnson, Christopher N. ;
Heightman, Tom D. .
ACS CENTRAL SCIENCE, 2016, 2 (12) :927-934
[32]   Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 [J].
Lu, Jing ;
Qian, Yimin ;
Altieri, Martha ;
Dong, Hanqing ;
Wang, Jing ;
Raina, Kanak ;
Hines, John ;
Winkler, James D. ;
Crew, Andrew P. ;
Coleman, Kevin ;
Crews, Craig M. .
CHEMISTRY & BIOLOGY, 2015, 22 (06) :755-763
[33]   Targeting HSP90 for cancer therapy [J].
Mahalingam, D. ;
Swords, R. ;
Carew, J. S. ;
Nawrocki, S. T. ;
Bhalla, K. ;
Giles, F. J. .
BRITISH JOURNAL OF CANCER, 2009, 100 (10) :1523-1529
[34]   The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models [J].
Miyajima, Naoto ;
Tsutsumi, Shinji ;
Sourbier, Carole ;
Beebe, Kristin ;
Mollapour, Mehdi ;
Rivas, Candy ;
Yoshida, Soichiro ;
Trepel, Jane B. ;
Huang, Ying ;
Tatokoro, Manabu ;
Shinohara, Nobuo ;
Nonomura, Katsuya ;
Neckers, Len .
CANCER RESEARCH, 2013, 73 (23) :7022-7033
[35]   CHEMICAL BIOLOGY Greasy tags for protein removal [J].
Neklesa, Taavi K. ;
Crews, Craig M. .
NATURE, 2012, 487 (7407) :308-309
[36]  
Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/nchembio.597, 10.1038/NCHEMBIO.597]
[37]  
Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556
[38]   Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins [J].
Pellinen, Teijo ;
Arjonen, Antti ;
Vuoriluoto, Karoliina ;
Kallio, Katja ;
Fransen, Jack A. M. ;
Ivaska, Johanna .
JOURNAL OF CELL BIOLOGY, 2006, 173 (05) :767-780
[39]   Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations [J].
Perez-Torres, Marianela ;
Guix, Marta ;
Gonzalez, Adriana ;
Arteaga, Carlos L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (52) :40183-40192
[40]   Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein [J].
Peschard, P ;
Fournier, TM ;
Lamorte, L ;
Naujokas, MA ;
Band, H ;
Langdon, WY ;
Park, M .
MOLECULAR CELL, 2001, 8 (05) :995-1004